|
Study day
|
Estimated percent hair re-growth
a
|
|---|
|
Bravecto
™b
(number of dogs/number of dogs per group)
|
Advocate®
c
(number of dogs/number of dogs per group)
|
|---|
|
0-50%
|
50-90%
|
>90%
|
0-50%
|
50-90%
|
>90%
|
|---|
|
28
|
3/8
|
1/8
|
4/8
|
6/8
|
1/8
|
1/8
|
|
56
|
0/8
|
1/8
|
7/8
|
0/8
|
1/8
|
7/8
|
|
84
|
0/8
|
1/8
|
7/8
|
0/7d
|
1/7d
|
6/7d
|
-
aPercentage hair re-growth defined as estimated percentage of hair cover growth compared to baseline total hairless area as assessed prior to veterinary product administration.
-
bDogs were treated once orally on Day 0.
-
cDogs were treated topically on Day 0, on Day 28 and again on Day 56. Hair assessments were performed before treatment.
-
dOn day 59 one dog had to be euthanized due to the presence of a malign tumour in the stomach.
